Approved Company
GlycoVaxyn
Address: NO DATA
Website: NO DATA
Country(s): Switzerland
Supported Region(s): Europe
Description

GlycoVaxyn GlycoVaxyn is a private Swiss biotechnology company developing a broad portfolio of novel bioconjugate vaccines to prevent and treat common, severe bacterial infections using its proprietary glycoprotein technology.

Service Category(s)
Key Service(s)
Life Science Sector
Certificates
NO DATA